UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast


UnitedHealth Group (UNH) stock forecast, based on 51 Wall Street analysts, predicts a 12-month average price target of $385.00, with a high of $444.00 and a low of $198.00. This represents a 36.19% increase from the last price of $282.70.

$150 $250 $350 $450 $550 $650 High: $444 Avg: $385 Low: $198 Last Closed Price: $282.7

UNH Stock Rating


UnitedHealth Group stock's rating consensus is Buy, based on 51 Wall Street analysts. The breakdown includes 1 Strong Buy (1.96%), 39 Buy (76.47%), 7 Hold (13.73%), 4 Sell (7.84%), and 0 Strong Sell (0.00%).

Buy
Total 51 4 7 39 1 Strong Sell Sell Hold Buy Strong Buy

UNH Price Target Upside V Benchmarks


TypeNameUpside
StockUnitedHealth Group36.19%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks26.04%

Price Target Trends


1M3M12M
# Anlaysts101741
Avg Price Target$396.00$400.76$389.49
Last Closing Price$282.70$282.70$282.70
Upside/Downside40.08%41.76%37.78%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2661362-27
Dec, 2561262-26
Nov, 2551372-27
Oct, 2551362-26
Sep, 2561352-26
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 28, 2026RBC Capital$361.00$291.2523.95%27.70%
Jan 28, 2026KeyBanc$405.00$288.0140.62%43.26%
Jan 28, 2026UBS$410.00$291.0040.89%45.03%
Jan 28, 2026Michael WiederhornOppenheimer$385.00$282.7036.19%36.19%
Jan 28, 2026Erin WrightMorgan Stanley$375.00$282.7032.65%32.65%
Jan 28, 2026Leerink Partners$345.00$282.7022.04%22.04%
Jan 27, 2026Piper Sandler$396.00$281.7340.56%40.08%
Jan 25, 2026Erin WrightMorgan Stanley$409.00$356.2614.80%44.68%
Jan 06, 2026Bernstein$444.00$348.5527.38%57.06%
Jan 06, 2026Elizabeth AndersonEvercore ISI$400.00$342.0216.95%41.49%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 28, 2026BernsteinOutperformOutperformhold
Jan 28, 2026UBSBuyBuyhold
Jan 28, 2026OppenheimerOutperformOutperformhold
Jan 27, 2026Piper SandlerOverweightOverweighthold
Jan 25, 2026Morgan StanleyOverweightOverweighthold
Jan 06, 2026BernsteinOutperformOutperformhold
Jan 06, 2026Evercore ISIOutperforminitialise
Jan 05, 2026BarclaysOverweightOverweighthold
Oct 30, 2025Cowen & Co.HoldHoldhold
Oct 30, 2025BernsteinOutperformOutperformhold

Financial Forecast


EPS Forecast

$15 $23 $31 $39 $47 $55 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$18.33$21.54$24.12$15.51-----
Avg Forecast$18.84$22.02$24.96$27.61$29.72$33.50$38.08$43.85$50.63
High Forecast$19.18$22.77$25.02$27.79$30.08$34.27$39.69$44.83$51.76
Low Forecast$18.46$21.33$24.87$27.30$28.45$32.22$35.72$42.05$48.55
Surprise %-2.71%-2.18%-3.37%-43.82%-----

Revenue Forecast

$250B $340B $430B $520B $610B $700B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$285.27B$322.13B$367.53B$400.28B-----
Avg Forecast$286.74B$323.88B$369.14B$400.99B$450.84B$486.57B$522.61B$589.76B$675.82B
High Forecast$290.73B$332.33B$370.46B$402.87B$453.61B$497.97B$523.71B$599.90B$687.44B
Low Forecast$282.29B$316.03B$367.79B$400.03B$441.53B$469.85B$521.51B$571.09B$654.43B
Surprise %-0.51%-0.54%-0.44%-0.18%-----

Net Income Forecast

$10B $18B $26B $34B $42B $50B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.29B$20.12B$22.38B$14.40B-----
Avg Forecast$15.70B$17.98B$22.38B$25.59B$27.19B$30.89B$35.03B$40.74B$47.04B
High Forecast$18.84B$21.58B$26.86B$25.81B$27.95B$31.83B$36.87B$41.65B$48.09B
Low Forecast$12.56B$14.39B$17.90B$25.36B$26.43B$29.94B$33.18B$39.06B$45.10B
Surprise %10.10%11.89%--43.70%-----

UNH Forecast FAQ


Is UnitedHealth Group stock a buy?

UnitedHealth Group stock has a consensus rating of Buy, based on 51 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 39 Buy, 7 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that UnitedHealth Group is a favorable investment for most analysts.

What is UnitedHealth Group's price target?

UnitedHealth Group's price target, set by 51 Wall Street analysts, averages $385 over the next 12 months. The price target range spans from $198 at the low end to $444 at the high end, suggesting a potential 36.19% change from the previous closing price of $282.7.

How does UnitedHealth Group stock forecast compare to its benchmarks?

UnitedHealth Group's stock forecast shows a 36.19% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (26.04%).

What is the breakdown of analyst ratings for UnitedHealth Group over the past three months?

  • January 2026: 22.22% Strong Buy, 48.15% Buy, 22.22% Hold, 7.41% Sell, 0% Strong Sell.
  • December 2025: 23.08% Strong Buy, 46.15% Buy, 23.08% Hold, 7.69% Sell, 0% Strong Sell.
  • November 2025: 18.52% Strong Buy, 48.15% Buy, 25.93% Hold, 7.41% Sell, 0% Strong Sell.

What is UnitedHealth Group’s EPS forecast?

UnitedHealth Group's average annual EPS forecast for its fiscal year ending in December 2025 is $29.72, marking a 91.62% increase from the reported $15.51 in 2024. Estimates for the following years are $33.5 in 2026, $38.08 in 2027, $43.85 in 2028, and $50.63 in 2029.

What is UnitedHealth Group’s revenue forecast?

UnitedHealth Group's average annual revenue forecast for its fiscal year ending in December 2025 is $450.84B, reflecting a 12.63% increase from the reported $400.28B in 2024. The forecast for 2026 is $486.57B, followed by $522.61B for 2027, $589.76B for 2028, and $675.82B for 2029.

What is UnitedHealth Group’s net income forecast?

UnitedHealth Group's net income forecast for the fiscal year ending in December 2025 stands at $27.19B, representing an 88.73% increase from the reported $14.4B in 2024. Projections indicate $30.89B in 2026, $35.03B in 2027, $40.74B in 2028, and $47.04B in 2029.